Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $45.81 +2.99%
Revenue Growth %: +15.2%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +15.2%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Faraday Future says it regained Nasdaq compliance after equity shortfall
- Community Financial System Announces Third Quarter 2026 Earnings Conference Call
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
